Dextech Medical AB (XSAT:DEX)

Dextech Medical AB Balance Sheet

Financials in millions SEK. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	12.21	14.71	19.04	25.24	35.47	3.46
Cash & Short-Term Investments	12.21	14.71	19.04	25.24	35.47	3.46
Cash Growth	-25.18%	-22.76%	-24.54%	-28.86%	926.20%	-43.25%
Other Receivables	0.47	0.09	0.13	0.11	0.2	0.03
Receivables	0.47	0.09	0.13	0.11	0.2	0.03
Other Current Assets	-	0.38	0.5	0.47	0.35	0.26
Total Current Assets	12.68	15.18	19.68	25.82	36.02	3.75
Long-Term Investments	-	0	0	0	0	0
Other Intangible Assets	9.64	0.25	0.25	0.25	0.39	0.54
Long-Term Deferred Charges	-	9.67	10.66	8.97	3.18	2.94
Other Long-Term Assets	0	-	-	-	-	-
Total Assets	22.32	25.1	30.59	35.03	39.59	7.23
Accounts Payable	-	0.13	0.28	0.15	0.25	0.04
Accrued Expenses	-	0.18	0.69	0.55	0.43	0.15
Other Current Liabilities	0.44	0.02	0.01	0.02	0.03	0.03
Total Current Liabilities	0.44	0.34	0.98	0.72	0.71	0.22
Total Liabilities	0.44	0.34	0.98	0.72	0.71	0.22
Common Stock	21.88	0.83	0.83	0.83	0.83	0.67
Additional Paid-In Capital	-	105.2	105.2	105.2	105.2	68.22
Retained Earnings	-	-81.26	-76.42	-71.71	-67.15	-61.88
Shareholders' Equity	21.88	24.76	29.61	34.31	38.88	7.02
Total Liabilities & Equity	22.32	25.1	30.59	35.03	39.59	7.23
Net Cash (Debt)	12.21	14.71	19.04	25.24	35.47	3.46
Net Cash Growth	-25.18%	-22.76%	-24.54%	-28.86%	926.20%	-43.25%
Net Cash Per Share	0.66	0.79	1.01	1.37	2.09	0.23
Filing Date Shares Outstanding	18.49	18.49	18.49	18.49	18.49	14.92
Total Common Shares Outstanding	18.49	18.49	18.49	18.49	18.49	14.92
Working Capital	12.24	14.85	18.7	25.1	35.31	3.54
Book Value Per Share	1.18	1.34	1.60	1.86	2.10	0.47
Tangible Book Value	12.24	24.51	29.36	34.07	38.49	6.47
Tangible Book Value Per Share	0.66	1.33	1.59	1.84	2.08	0.43

Source: S&P Global Market Intelligence. Standard template. Financial Sources.